- Report
- March 2020
- 137 Pages
Global
From €4327EUR$4,899USD£3,695GBP
- Report
- May 2024
- 321 Pages
Global
From €5271EUR$6,178USD£4,350GBP
- Report
- March 2024
- 239 Pages
Global
From €5271EUR$6,178USD£4,350GBP
- Report
- March 2024
- 373 Pages
Global
From €5271EUR$6,178USD£4,350GBP
- Report
- January 2024
- 263 Pages
Global
From €5271EUR$6,178USD£4,350GBP
- Report
- October 2023
- 192 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- November 2023
- 215 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- September 2023
- 303 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- September 2023
- 249 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- September 2023
- 231 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- August 2023
- 262 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- June 2023
- 364 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- May 2023
- 274 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- May 2023
- 375 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- April 2023
- 272 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- April 2023
- 230 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- January 2023
- 262 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- January 2023
- 239 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- November 2022
- 285 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- September 2022
- 275 Pages
Global
From €3091EUR$3,500USD£2,640GBP

The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more